store at low temperature,keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GNE-900 is an ATP-competitive ChK1 inhibitor with selective and oral activity.GNE-900 inhibits ChKl and ChK2 with IC50 values of 0.0011 and 1.5 µM, respectively.GNE-900 enhances DNA damage and induces apoptosis. GNE-900 has antitumor activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 67.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 289.00 | |
25 mg | In stock | $ 487.00 | |
50 mg | In stock | $ 696.00 | |
100 mg | In stock | $ 987.00 |
Description | GNE-900 is an ATP-competitive ChK1 inhibitor with selective and oral activity.GNE-900 inhibits ChKl and ChK2 with IC50 values of 0.0011 and 1.5 µM, respectively.GNE-900 enhances DNA damage and induces apoptosis. GNE-900 has antitumor activity. |
Targets&IC50 | Chk1:0.0011 μM, Chk2:1.5 μM |
In vitro | GNE-900 (1 µM; 1-48 h; HT-29 cells) induces apoptosis and increases expression of cleaved PARP when combined with gemcitabine (50 nM) in HT-29 cells.[1] |
In vivo | GNE-900 (2.5-40 mg/kg; p.o.; once; Sprague-Dawley rats) combined with gemcitabine (120 mg/kg) reduced tumor volume and increased DNA damage and γ-H2AX expression levels in rats.[1] |
Synonyms | GNE900, GNE 900 |
Molecular Weight | 367.45 |
Formula | C23H21N5 |
CAS No. | 1200126-26-6 |
store at low temperature,keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GNE-900 1200126-26-6 Apoptosis Cell Cycle/Checkpoint Chk GNE900 GNE 900 Omeprazole acid inhibitor inhibit